HEPATIC FIBROSIS-AMELIORATING AGENT

Title:

HEPATIC FIBROSIS-AMELIORATING AGENT

Document Type and Number:

WIPO Patent Application WO/2016/139740

Kind Code:

A1

Abstract:

[Problem] To verify an advantage in terms of hepatic fibrosis-ameliorating effect in hepatitis/hepatic cirrhosis using a thioacetamide hepatic dysfunction model, and provide this advantage. [Solution] This advantage is achieved by means of a compounding agent that includes zinc and selenium.

More Like This:

WO/2001/070390	PRODUCTION OF MAGNESIUM SUPERMAG COMPLEXES
WO/2021/136862	LIQUID GALENIC COMPOSITION FOR ORAL USE COMPRISING MELATONIN AND A ZINC SALT, AND CORRESPONDING METHOD AND USE
JP2010540542	Power generation fine particles and their use

Inventors:

KUBOTA SATORU (JP)
KONO TORU (JP)

Application Number:

PCT/JP2015/056147

Publication Date:

September 09, 2016

Filing Date:

March 03, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDICO CONSL CO LTD (JP)

International Classes:

A61K33/30; A61K33/04; A61K47/02; A61K47/22; A61P1/16

Other References:

TORU KONO ET AL.: "Aen Selenium Fukugo Eiyo Kino Shokuhin ni yoru Kan Sen'ika Yokusei Koka ni Tsuite no Dobutsu Model deno Kento", JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY TAIKAI KOEN YOSHISHU, vol. 2013, 5 March 2013 (2013-03-05), pages 2A16 p04
TAKASHI HIMOTO ET AL.: "Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease", NUTRITION RESEARCH, vol. 31, 2011, pages 829 - 835, XP028597906, DOI: doi:10.1016/j.nutres.2011.09.021
TAKASHI HIMOTO ET AL.: "Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease", SCAND J GASTROENTEROL., vol. 42, 2007, pages 1078 - 1087

Attorney, Agent or Firm:

MIYAZAKI, Tadaaki et al. (JP)
Miyazaki Tadaaki (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: STEERING WHEEL AND MANUFACTURING METHOD FOR SAME

Next Patent: REEL SUPPORTING DEVICE